RXST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the investor's beginner level, long-term strategy, and available capital, RXST does not currently present a strong buy opportunity. The stock lacks positive momentum, has mixed analyst ratings, and faces declining revenue trends. Additionally, no significant catalysts or trading signals support immediate action.
The MACD is positive but contracting, RSI is neutral at 50.094, and moving averages are converging, indicating no clear trend. Key support is at 6.74, and resistance is at 7.619. The stock is trading near its pivot point of 7.18.
Gross margin improved to 77.47%, up 8.21% YoY. EPS and net income have shown significant improvement YoY.
Analysts have lowered price targets, and the stock lacks strong trading signals or recent positive news. Stock trend analysis predicts a potential decline in the short to medium term.
In Q4 2025, revenue dropped to $32.61M (-18.91% YoY), while net income improved to -$9.15M (+54.13% YoY). EPS increased to -0.22 (+46.67% YoY), and gross margin improved to 77.47% (+8.21% YoY).
Analysts are neutral to cautious, with price targets ranging from $9 to $10. Recent updates reflect concerns about the company's growth outlook and revenue guidance for 2026 being below estimates.
